In the ICE-AFIB Trial, patients who received concomitant Cox-Maze III lesions using the cryoICE cryoFORM® Cryoablation probe during cardiac surgery experienced improvements in quality of life.*
Mean QoL scores* improved by +32 points at 12 and 24 months compared to baseline – demonstrating durable benefit over time.
Read the full study: <a href="https://okt.to/qlLImZ" target="_blank">https://okt.to/qlLImZ</a>
*As calculated from the Atrial Fibrillation Effect on Quality of Life (AFEQT) questionnaire. A 5-point change is considered clinically meaningful.
